Clinical trial

Masitinib in Refractory Active Rheumatoid Arthritis

NCT01410695

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-07-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2011-07-01Date precision: month

Registry last updated2018-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritis (RA)unresolved

Interventions

masitinib 3 mgDRUG

masitinib 6.0 mgDRUG

methotrexateDRUG

Placebo (methotrexate)DRUG

Placebo (masitinib)DRUG

Sponsors & collaborators

AB Sciencelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01410695 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.